What is the recommended insulin therapy for pregnant women with diabetes?

Insulin Therapy in Pregnancy

Primary Recommendation

Insulin is the mandatory and preferred medication for managing all types of diabetes during pregnancy, as it does not cross the placenta and provides the safest option for both mother and fetus. 1, 2

---

Insulin Type Selection

For Type 1 Diabetes

• Insulin is mandatory for management of type 1 diabetes in pregnancy 1, 2
• Either multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII/pump) are equally acceptable delivery methods, with neither shown to be superior 1, 3

For Type 2 Diabetes

• Insulin is the preferred treatment for type 2 diabetes in pregnancy 1
• Women on oral hypoglycemic agents should transition to insulin therapy 4
• Higher insulin doses are often required, sometimes necessitating concentrated insulin formulations 1

For Gestational Diabetes

• Insulin is indicated when medical nutrition therapy and lifestyle modifications fail to achieve glycemic targets 5, 6

---

Preferred Insulin Formulations

Rapid-Acting Insulins (Prandial Coverage)

• Insulin lispro and insulin aspart are the preferred rapid-acting insulins, as they have been studied in randomized controlled trials and demonstrate established safety in pregnancy 3, 7, 8
• These analogs reduce postprandial glucose more effectively than regular human insulin with less hypoglycemia risk 6

Long-Acting Insulins (Basal Coverage)

• Insulin detemir and NPH insulin are the preferred long-acting options for basal coverage 3, 9
• NPH insulin remains an acceptable alternative, particularly in resource-limited settings or when cost is a concern 3
• Insulin glargine can be considered acceptable despite limited randomized trial data, particularly for women already well-controlled on this regimen pre-pregnancy 3, 10

---

Initial Dosing Strategy

Calculate total daily insulin dose as 0.5 units/kg/day based on current body weight, with division of 50% basal insulin and 50% prandial insulin distributed across three meals 3

---

Glycemic Targets During Pregnancy

Blood Glucose Targets

• Fasting glucose: 70-95 mg/dL 3, 2
• 1-hour postprandial: 110-140 mg/dL 3, 2
• 2-hour postprandial: <120 mg/dL 3, 2

A1C Targets

• Optimal target: <6% if achievable without significant hypoglycemia 3, 2
• Alternative targets: <6.5% or <7% if necessary to prevent hypoglycemia 2

---

Monitoring Requirements

• Perform blood glucose monitoring 4-6 times daily to guide insulin dose adjustments 3, 2
• Monitor A1C monthly throughout pregnancy 3
• Regular evaluation of insulin requirements is necessary every 2-3 weeks as pregnancy progresses 2

---

Insulin Requirements Throughout Pregnancy

First Trimester (Weeks 10-16)

• Insulin requirements decrease by 12% due to enhanced insulin sensitivity and increased hypoglycemia risk 3, 2
• Hypoglycemia risk is highest during this period with altered counterregulatory responses 3, 2

Second and Third Trimester (Weeks 17-36)

• Insulin resistance develops, requiring 2-3 fold increases in total daily dose 3
• After 28 weeks gestation, insulin needs rise by approximately 62% from early pregnancy levels 3

Postpartum Period

• Insulin requirements drop precipitously after placental delivery 3, 2
• Resume insulin at either 80% of pre-pregnancy doses or 50% of end-of-pregnancy doses immediately postpartum to prevent hypoglycemia 3, 2
• Close monitoring is required in the immediate postpartum period 3, 2

---

Critical Clinical Pitfalls

Placental Insufficiency Warning

• A rapid reduction in insulin requirements may indicate placental insufficiency and requires immediate obstetric evaluation 3, 2

Diabetic Ketoacidosis (DKA)

• Monitor for DKA at lower glucose thresholds during pregnancy (<200-250 mg/dL versus typical >250 mg/dL) 2
• Women in DKA who cannot eat often require 10% dextrose with insulin drip to meet higher carbohydrate demands of the placenta and fetus in the third trimester 1

Hypoglycemia Prevention

• Provide comprehensive education on hypoglycemia prevention, recognition, and treatment to patients and family members before initiating insulin 3, 2
• Pregnant patients with type 1 diabetes have increased hypoglycemia risk in the first trimester 3

---

Adjunctive Therapy

Preeclampsia Prevention

• Prescribe low-dose aspirin 100-150 mg/day (or 162 mg/day) starting at 12-16 weeks of gestation to lower the risk of preeclampsia 1
• Low-dose aspirin <100 mg is not effective; doses >100 mg are required 1

Blood Pressure Management

• Target blood pressure of 110-135/85 mmHg to reduce risk of accelerated maternal hypertension and minimize impaired fetal growth 1
• Stop ACE inhibitors, angiotensin receptor blockers, and statins at conception, as they are contraindicated in pregnancy 1

---

Specialized Care Recommendation

Due to the complexity of insulin management in pregnancy, referral to a specialized diabetes and pregnancy center offering team-based care is strongly recommended for optimal maternal and fetal outcomes 1, 3, 2. The team should include a maternal-fetal medicine specialist, endocrinologist or provider experienced in managing pregnancy with preexisting diabetes, dietitian, nurse, and social worker 1.